Estrogen Receptor Negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Estrogen Receptor Negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy [NA]
A multicenter MD Anderson trial investigates eliminating breast cancer surgery or radiotherapy in exceptional responders to neoadjuvant syst…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Sacituzumab Govitecan In TNBC [Phase 2]
Phase 2 study of Sacituzumab Govitecan in triple-negative breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs [Phase 2]
A Phase 2 trial of datopotamab deruxtecan (DATO-BASE) for breast cancer with brain metastases is currently recruiting.
-
CLINICAL_TRIALS research · 2014-09-12Clinical Trial Update: Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer [Phase 1]
A completed Phase 1 trial evaluating defined green tea catechin extract in women with hormone receptor-negative breast cancer (Stage I-III).